• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Biocon Limited — Board Meeting, 12-02-2026: Outcome of Board Meeting

    12-02-2026 | 07:10 pm

    Biocon's board approved Q3 & 9M FY26 consolidated results, reporting revenue of ₹4,173 Cr and profit for shareholders of ₹143.8 Cr. The board also approved acquiring the remaining ~2% stake in Biocon Biologics via share issuance, making BBL a wholly-owned subsidiary.

    No comments yet. Be the first to comment!

    All announcements from Biocon Limited